Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Yossepowitch

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
European Urology|November 13, 2007
Prostate cancer in men with serum PSA of <4 ng/ml: under-diagnosed or over-treated?Ofer Yossepowitch
European Urology Focus|July 30, 2017
Curing Lymph Node Metastasis in Prostate Cancer: The Ongoing Battle Between Improving Surgical Quality and Tumor BiologyOfer Yossepowitch
European Urology|August 4, 2007
This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HTOfer Yossepowitch
European Urology|March 21, 2009
Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancerOfer Yossepowitch
European Urology|May 13, 2014
Salvage lymph node dissection for biochemical recurrence following radical prostatectomy: is the evidence there?Ofer Yossepowitch
European Urology|June 9, 2009
Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patientsOfer Yossepowitch
European Urology|June 16, 2016
Re: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder CancerOfer Yossepowitch
The Journal of Urology|December 27, 2019
Editorial CommentOfer Yossepowitch
European Urology|April 15, 2008
Digital rectal examination remains an important screening tool for prostate cancerOfer Yossepowitch
The Journal of Urology|June 7, 2002
Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcomeOfer Yossepowitch, Guido Dalbagni
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
European Urology|November 13, 2007
Prostate cancer in men with serum PSA of <4 ng/ml: under-diagnosed or over-treated?Ofer Yossepowitch
European Urology Focus|July 30, 2017
Curing Lymph Node Metastasis in Prostate Cancer: The Ongoing Battle Between Improving Surgical Quality and Tumor BiologyOfer Yossepowitch
European Urology|August 4, 2007
This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HTOfer Yossepowitch
European Urology|March 21, 2009
Editorial comment on: tumor grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancerOfer Yossepowitch
European Urology|May 13, 2014
Salvage lymph node dissection for biochemical recurrence following radical prostatectomy: is the evidence there?Ofer Yossepowitch
European Urology|June 9, 2009
Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patientsOfer Yossepowitch
European Urology|June 16, 2016
Re: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder CancerOfer Yossepowitch
The Journal of Urology|December 27, 2019
Editorial CommentOfer Yossepowitch
European Urology|April 15, 2008
Digital rectal examination remains an important screening tool for prostate cancerOfer Yossepowitch
The Journal of Urology|June 7, 2002
Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcomeOfer Yossepowitch, Guido Dalbagni
Pageof 16